Home
Senores Pharmaceuticals Ltd Board of Directors
From Blinkx's GPT
Key Highlights
- SWAPNIL JATINBHAI SHAH continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Sanjay Majmudar continues to serve as the Chairman (Non-Executive) in 2024, maintaining the same position as in the previous year.
- Hemanshu Nitinchandra Pandya continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Jitendra Babulal Sanghvi continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Chetan Bipinchandra Shah continues to serve as the Whole Time Director & COO in 2024, maintaining the same position as in the previous year.
Senores Pharmaceuticals Ltd
NSE: SENORES
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 12 Mar 2025 | 576.35 |
| 11 Mar 2025 | 551.2 |
| 10 Mar 2025 | 548.75 |
| 07 Mar 2025 | 566.1 |
| 06 Mar 2025 | 593.75 |
| 05 Mar 2025 | 596.1 |
| 04 Mar 2025 | 562.2 |
| 03 Mar 2025 | 530.4 |
| 28 Feb 2025 | 543.75 |
| 27 Feb 2025 | 566.7 |
Company Fundamentals for Senores Pharmaceuticals Ltd
Market Cap
2,654 Cr
EPS
6.8
P/E Ratio (TTM)
84.3
P/B Ratio (TTM)
3.5
Day’s High
579.95
Day’s Low
553.65
DTE
1.3
ROE
15.4
52 Week High
644.4
52 Week Low
440.0
ROCE
7.4
Market Price of Senores Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Senores Pharmaceuticals Ltd News Hub
Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25
Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror
Read more
23 Jan 25
Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets
Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,
Read more
10 Jan 25
Senores Pharmaceuticals IPO subscribed 93.41 times
The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a
Read more
24 Dec 24
Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet
Senores Pharmaceuticals has received final approval from the United States Food and Drug Administrat
Read more
10 Jan 25
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Senores Pharmaceuticals Ltd
How are members of Senores Pharmaceuticals Ltd Board of Directors selected?
Members of the Senores Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Senores Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Senores Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Senores Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Senores Pharmaceuticals Ltd Board of Directors meet?
The Senores Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Senores Pharmaceuticals Ltd Board of Directors?
The Senores Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Senores Pharmaceuticals Ltd?
The current Board of Directors at Senores Pharmaceuticals Ltd includes SWAPNIL JATINBHAI SHAH( Managing Director) ,Sanjay Majmudar( Chairman (Non-Executive)) ,Hemanshu Nitinchandra Pandya( Non Executive Director) ,Jitendra Babulal Sanghvi( Independent Director) ,Chetan Bipinchandra Shah( Whole Time Director & COO) . The full list can be found on Senores Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
